Heart & blood pressure · Kansas City area, MO
Heart and blood pressure studies in Kansas City area, MO
41 recruiting studies have a site in the Kansas City area. This page includes nearby cities such as Independence, Lee's Summit, North Kansas City, Liberty.
41 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- Recruiting
THRIVE- THerapeutic IntravasculaR Ultrasound (TIVUS™) REnal Denervation System Versus Sham for the Adjunctive Treatment of Hypertension
SoniVie Inc.
- Location
- Kansas City, MO + 33 other US sites
- Eligibility basics
- Ages 22–75
- RecruitingPhase 1/Phase 2
ATR 1072 in Participants With PRKAG2 Syndrome
Atrium Therapeutics
- Location
- Kansas City, MO
- Eligibility basics
- Ages 18–65
- RecruitingPhase 3
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Amgen
- Location
- Kansas City, MO + 117 other US sites
- Eligibility basics
- Ages 18–99
- Recruiting
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
Medtronic Cardiovascular
- Location
- St Louis, MO + 68 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
BrioHealth Solutions, Inc.
- Location
- St Louis, MO + 46 other US sites
- Eligibility basics
- Ages 18–100
- RecruitingPhase 3
An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH)
Inhibikase Therapeutics
- Location
- St Louis, MO + 14 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
Eidos Therapeutics, a BridgeBio company
- Location
- Kansas City, MO + 39 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
Anthos Therapeutics, Inc.
- Location
- Kansa City, MO + 131 other US sites
- Eligibility basics
- Ages 65+
- Recruiting
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
Endotronix, Inc.
- Location
- Kansas City, MO + 43 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
DalCor Pharmaceuticals
- Location
- St Louis, MO + 112 other US sites
- Eligibility basics
- Ages 45+
- Recruiting
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
Abbott Medical Devices
- Location
- Kansas City, MO + 56 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
Intellia Therapeutics
- Location
- Kansas City, MO + 36 other US sites
- Eligibility basics
- Ages 18–90
- Recruiting
PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR
Edwards Lifesciences
- Location
- Kansas City, MO + 49 other US sites
- Eligibility basics
- Ages 65+
- Recruiting
Trial of the F2 Filter and Delivery System for Embolic Protection During TAVR
EnCompass Technologies, Inc.
- Location
- Kansas City, MO + 4 other US sites
- Eligibility basics
- Ages 50+
- RecruitingPhase 3
Fontan Udenafil Exercise Longitudinal Assessment Trial - 2
Mezzion Pharma Co. Ltd
- Location
- Kansas City, MO + 34 other US sites
- Eligibility basics
- Ages 12–18
- RecruitingHealthy volunteersPhase 4
Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults
Duke University
- Location
- Columbia, MO + 88 other US sites
- Eligibility basics
- Ages 75+
- RecruitingHealthy volunteers
International (Pediatric) Peritoneal Biobank
Heidelberg University
- Location
- Kansas City, MO
- Eligibility basics
- Ages 0 mo–90
Who these studies look for
Many require a diagnosis or specific lab values such as LDL cholesterol or blood pressure readings, and exclude recent heart events.
Matching a page like this one never means you qualify. Each research team decides eligibility at screening.